HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
104.88
+0.02 (0.02%)
At close: Jun 27, 2025, 4:00 PM
106.00
+1.12 (1.07%)
After-hours: Jun 27, 2025, 7:02 PM EDT
HealthEquity Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for HealthEquity stock ranges from a low of $100 to a high of $130. The average analyst price target of $117 forecasts a 11.56% increase in the stock price over the next year.
Price Target: $117.00 (+11.56%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 9 | 9 | 8 | 7 | 8 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $112 → $125 | Buy | Maintains | $112 → $125 | +19.18% | Jun 5, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $98 → $115 | Strong Buy | Maintains | $98 → $115 | +9.65% | Jun 5, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $94 → $104 | Hold | Maintains | $94 → $104 | -0.84% | Jun 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $112 → $117 | Buy | Maintains | $112 → $117 | +11.56% | Jun 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $110 → $125 | Strong Buy | Maintains | $110 → $125 | +19.18% | Jun 4, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.20B
Increased by 9.60%
Revenue Next Year
1.43B
from 1.32B
Increased by 9.05%
EPS This Year
3.75
from 1.09
Increased by 243.59%
EPS Next Year
4.44
from 3.75
Increased by 18.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | 1.7B |
| Avg | 1.3B | 1.4B | 1.6B |
| Low | 1.3B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.3% | 16.7% | 17.2% |
| Avg | 9.6% | 9.0% | 9.3% |
| Low | 5.9% | 4.0% | 3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.97 | 4.78 | 5.99 |
| Avg | 3.75 | 4.44 | 5.32 |
| Low | 3.53 | 4.17 | 4.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 264.1% | 27.6% | 34.7% |
| Avg | 243.6% | 18.6% | 19.7% |
| Low | 223.7% | 11.2% | 10.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.